pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,407 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT1013Endpoints769BioPharma Dive293BioSpace209Fierce Biotech197onclive165raps74globenewswire health
therapy area
allOncology5938Rare Disease1391Cardiology1080Hematology1007Immunology990Pulmonology892Vaccines
  • 340B Drug Discount Program sales hit $100 billion in 2025, up 22.8% year over year
    The Health Resources and Services Administration reported that purchases under the 340B discount program reached $100 billion in 2025, a 22.8% rise from 2024. Expensive medicines made up a growing…
    STAT · 1mo agoRegulatoryNeutral↗ source
  • HCA Healthcare cuts 2026 profit outlook as uninsured patient numbers rise after ACA subsidy expiration
    HCA Healthcare, the largest U.S. hospital chain, announced on Tuesday that it is lowering its profit outlook for 2026. The revision reflects a higher-than-expected number of uninsured patients in…
    STAT · 1mo agoNegative↗ source
← prev
page 23 of 57
next →
73
fda recalls44
fda medwatch39
fda press28
885
Psychiatry & CNS708
Ophthalmology416
Pain371
Endocrinology & Metabolism370
Infectious Disease346
  • Avere Therapeutics to go public via reverse merger, secures $320M to advance long-acting psoriasis pill
    Avere Therapeutics, a privately held immunology drug developer, announced a plan to become a public company through a reverse merger with NextCure. The transaction includes $320 million in new cap…
    BioPharma Dive · 1mo agoDealPositive↗ source
  • Biogen’s experimental Alzheimer’s drug diranersen slows cognitive decline in Phase 2, matching approved therapies
    Biogen reported that its experimental Alzheimer’s therapy diranersen slowed cognitive decline in a mid-stage Phase 2 study, achieving decline rates similar to those seen with drugs already on the m…
    STAT · 1mo agoPositive readoutPositive↗ source
  • Biogen's tau-targeting Alzheimer's drug shows cognitive slowing in mid-stage trial
    Biogen reported results from its mid-stage "Celia" trial testing the experimental tau-targeting antibody BIIB080 in patients with early Alzheimer's disease. The study compared three dose levels of…
    BioPharma Dive · 1mo agoPositive readoutPositive↗ source
  • Draig Therapeutics secures $65M Series B to advance brain-drug trials
    Draig Therapeutics announced a $65 million Series B financing led by Deep Track Capital, with participation from Janus Henderson Investors, Marshall Wace and other investors. The capital will fund…
    BioPharma Dive · 1mo agoDealPositive↗ source
  • Former FDA toxicologist says agency approved Zyn nicotine pouches without fully knowing their composition
    Former FDA toxicologist Christy Leppanen alleges the agency authorized Zyn nicotine pouches without complete safety data on the pouch material. Leppanen, who led a microplastics exposure project a…
    STAT · 1mo agoRegulatoryNegative↗ source
  • Deepfake videos of doctors threaten trust in telehealth and digital care
    A patient recently presented a video that appeared to show her physician in a white coat, recommending an over‑the‑counter hormone supplement and disparaging standard treatments. The doctor confirm…
    STAT · 1mo agoNegative↗ source
  • Alcohol Use Remains Leading Cause of Death in U.S., New Data Highlights Hidden Epidemic
    STAT's latest series reveals that alcohol kills more Americans each year than all illicit drugs combined, yet it remains largely overlooked by health officials and the public. Ten charts illustrat…
    STAT · 1mo agoNegative↗ source
  • AI competition shows better data beats larger models in drug metabolism predictions
    Inductive Bio emerged as the winner of a recent drug metabolism AI competition, but the final standings revealed a 28-way statistical tie, underscoring that the quality of data can outweigh model s…
    STAT · 1mo agoPositive readoutPositive↗ source
  • Cayman court orders Apple Tree Partners’ general partner to give up control of venture fund
    A Cayman Islands court ruled that Seth Harrison, the general partner of biotech venture firm Apple Tree Partners, must relinquish oversight of the fund. The order could shift management to two cour…
    BioPharma Dive · 1mo agoRegulatoryNegative↗ source
  • Anthropic launches Claude Science AI platform for biotech labs in Kendall Square
    Anthropic has introduced Claude Science, an application that tailors its large language model for use in biopharma research laboratories. The tool is being positioned for the Kendall Square biotech…
    STAT · 1mo agoNeutral↗ source
  • Former Akero executives team up with Fairmount to launch new immunology company
    The former executive team of Akero Therapeutics, which was recently acquired by Novo Nordisk, has announced the formation of a new immunology-focused company. They are partnering with investment fi…
    STAT · 1mo agoNeutral↗ source
  • US appeals court revives Teva lawsuit alleging Lilly breached generic Forteo agreement
    A U.S. appeals court has revived a lawsuit filed by Teva Pharmaceuticals against Eli Lilly. The case alleges that Lilly broke an agreement that permitted Teva to sell a generic version of Lilly's o…
    STAT · 1mo agoNegative↗ source
  • Cyclospora infections hit record high in 2026, Michigan officials suspect lettuce as source
    Infections caused by the parasite Cyclospora have surged to a record level in 2026, with more than 30 states reporting cases that now exceed the previous U.S. high of about 4,700 set in 2019. The…
    STAT · 1mo agoNegative↗ source
  • Democratic senators raise concerns over credibility and conflicts in RFK Jr.'s health-care advisory panel
    Two senior Democratic senators sent a letter to Health Secretary Robert F. Kennedy Jr. and CMS Administrator Mehmet Oz, saying they have serious concerns about the credibility and financial conflic…
    STAT · 1mo agoRegulatoryNegative↗ source
  • Newborn vitamin K refusal linked to bleeding risk as Ebola center workers strike over unpaid wages
    A recent STAT newsletter highlighted the dangers of declining the standard vitamin K injection for newborns, noting that refusal can increase the chance of serious bleeding in infants. The piece e…
    STAT · 1mo agoNeutral↗ source
  • STAT outlines 12 actionable steps to curb U.S. alcohol-related deaths
    STAT's investigative series examined the U.S. alcohol epidemic by interviewing over a hundred researchers, clinicians, patients, industry insiders and lawmakers. The reporters also reviewed scienti…
    STAT · 1mo agoPositive↗ source
  • Experts hail new pancreatic cancer drug daraxonrasib as biggest breakthrough in decades
    A conference in London brought together international pancreatic cancer researchers to discuss the latest advances. The meeting quickly shifted focus when a new drug, daraxonrasib, was highlighted…
    STAT · 1mo agoPositive↗ source
  • Agenus redirects late-stage colorectal trial to pre-surgery setting, shares double; Oxford Ebola vaccine enters Phase 1
    Agenus announced it will stop financially supporting its late-stage trial of the BOT+BAL immunotherapy combination in late-line colorectal cancer. The company will instead use recent $340 million…
    BioPharma Dive · 1mo agoNeutral↗ source
  • States' Medicaid cuts threaten financial stability of family caregivers for disabled adults
    Several states are proposing steep reductions in wages for family caregivers who provide care to people with disabilities as they grapple with Medicaid funding shortfalls. The article highlights t…
    STAT · 1mo agoRegulatoryNegative↗ source
  • AIDS activists criticize Biden-Gilead R&D settlement over HIV prevention patents
    A group of AIDS activists have secured an R&D agreement that sits at the core of a settlement between the U.S. government and Gilead Sciences concerning patents on HIV prevention drugs. The activi…
    STAT · 1mo agoRegulatoryNegative↗ source
  • Freenome's updated blood test shows stronger detection of precancerous lesions, boosting Abbott's market prospects
    Freenome announced that its revised SimpleScreen CRC blood test met both primary and secondary goals in a pivotal validation study. The new data indicate better performance than the earlier version…
    BioPharma Dive · 1mo agoPositive readoutPositive↗ source
  • Q32 Bio’s alopecia drug bempikibart meets Phase 2 goal, driving shares up 80%
    Q32 Bio reported that its experimental alopecia areata therapy, bempikibart, achieved the primary endpoint in the second part of a Phase 2 trial. Two‑fifths of participants grew enough hair to cove…
    BioPharma Dive · 1mo agoPositive readoutPositive↗ source
  • US faces critical shortage of forensic pathologists, delaying justice and public health
    The United States is experiencing a severe deficit of forensic pathologists, with roughly 850 currently practicing-about 400 fewer than experts say are needed to handle more than three million deat…
    STAT · 1mo agoNegative↗ source